These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38953619)

  • 1. Simultaneous Inference of Multiple Binary Endpoints in Biomedical Research: Small Sample Properties of Multiple Marginal Models and a Resampling Approach.
    Budig S; Jung K; Hasler M; Schaarschmidt F
    Biom J; 2024 Jul; 66(5):e202300197. PubMed ID: 38953619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous inference for multiple marginal generalized estimating equation models.
    Ristl R; Hothorn L; Ritz C; Posch M
    Stat Methods Med Res; 2020 Jun; 29(6):1746-1762. PubMed ID: 31526178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous inference of a binary composite endpoint and its components.
    Große Ruse M; Ritz C; Hothorn LA
    J Biopharm Stat; 2017; 27(1):56-69. PubMed ID: 26881805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous small-sample comparisons in longitudinal or multi-endpoint trials using multiple marginal models.
    Pallmann P; Ritz C; Hothorn LA
    Stat Med; 2018 Apr; 37(9):1562-1576. PubMed ID: 29444546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach for sizing trials with composite binary endpoints using anticipated marginal values and accounting for the correlation between components.
    Bofill Roig M; Gómez Melis G
    Stat Med; 2019 May; 38(11):1935-1956. PubMed ID: 30637797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-II generalized family-wise error rate formulas with application to sample size determination.
    Delorme P; de Micheaux PL; Liquet B; Riou J
    Stat Med; 2016 Jul; 35(16):2687-714. PubMed ID: 26914402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resampling dependent concordance correlation coefficients.
    Williamson JM; Crawford SB; Lin HM
    J Biopharm Stat; 2007; 17(4):685-96. PubMed ID: 17613648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resampling-based empirical Bayes multiple testing procedures for controlling generalized tail probability and expected value error rates: focus on the false discovery rate and simulation study.
    Dudoit S; Gilbert HN; van der Laan MJ
    Biom J; 2008 Oct; 50(5):716-44. PubMed ID: 18932138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of multiplicity adjustment strategies for correlated binary endpoints.
    Leon AC; Heo M
    J Biopharm Stat; 2005; 15(5):839-55. PubMed ID: 16080237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tukey trend test: Multiplicity adjustment using multiple marginal models.
    Schaarschmidt F; Ritz C; Hothorn LA
    Biometrics; 2022 Jun; 78(2):789-797. PubMed ID: 33559878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient and flexible multiplicity adjustment for chi-square endpoints.
    Wagler A; McCann M
    Math Biosci Eng; 2021 Jun; 18(5):4971-4986. PubMed ID: 34517473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes.
    Vickerstaff V; Omar RZ; Ambler G
    BMC Med Res Methodol; 2019 Jun; 19(1):129. PubMed ID: 31226934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bootstrap inference when using multiple imputation.
    Schomaker M; Heumann C
    Stat Med; 2018 Jun; 37(14):2252-2266. PubMed ID: 29682776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling the family-wise error rate in multi-arm, multi-stage trials.
    Crouch LA; Dodd LE; Proschan MA
    Clin Trials; 2017 Jun; 14(3):237-245. PubMed ID: 28545335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying differentially expressed genes using false discovery rate controlling procedures.
    Reiner A; Yekutieli D; Benjamini Y
    Bioinformatics; 2003 Feb; 19(3):368-75. PubMed ID: 12584122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power and sample size determination in clinical trials with multiple primary continuous correlated endpoints.
    Lafaye de Micheaux P; Liquet B; Marque S; Riou J
    J Biopharm Stat; 2014; 24(2):378-97. PubMed ID: 24605975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing additional benefit in noninferiority trials.
    Kieser M; Stucke K
    Biom J; 2016 Jan; 58(1):154-69. PubMed ID: 24979706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method.
    Dwivedi AK; Mallawaarachchi I; Alvarado LA
    Stat Med; 2017 Jun; 36(14):2187-2205. PubMed ID: 28276584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.